Emergent BioSolutions (EBS) Tops Q1 View; Reaffirms FY08 Guidance
Tweet Send to a Friend
Emergent BioSolutions Inc. (NYSE: EBS) reports Q1 EPS of $0.24, 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
